U.S. Rep. Diana DeGette , D-CO, and Rep. Charlie Dent, R-Pa, reintroduced legislation to support embryonic stem cell research. The representatives are co-sponsoring the Stem Cell Research Advancement Act of 2011, H.R. 2376. The bill would codify the National Institutes of Health’s guidelines for carrying out all stem-cell research and require the NIH to review […]
Celebrating 30 years of Biotechnology Innovation: From Diamond v. Chakrabarty to Today Thursday June 30, 2011 9:00-11:00AM Walter E. Washington Convention Center Room 102AB This event co-sponsored by the US Patent and Trademark Office, The Biotechnology Industry Organization and the Biojudiciary Project will celebrate the 30th anniversary of the issuance of the patent from the […]
You can keep up with what’s happening at BIO 2011 on BIOTechNOW (@BIOTechNOW) plus all the BIO Official Bloggers hitting the floor at the convention. I’ll be in attendance as well as participating in the BIO Official Blogger network throughout the week. If you’d like to meet up during the conference, drop me a […]
If you’re attending the BIO International Convention in Washington, DC on June 27-30th here are some of the sessions covering issues in biotech patenting and technology transfer: Drug Patent Linkage and Compulsory Licensing – Challenges of Working Patented Inventions in India for Pharma Sector Monday, June 27, 2:00 pm – 3:15 pm. The session deals […]
Recently, Vaughan Barlow details the ramifications of the Patent Amendment (Human Genes and Biological Materials) Bill (2010), currently being debated before the Australian parliament. The Bill seeks to ban the patenting of all biological material that is “identical or substantially identical to such materials as they exist in nature”. If passed, this legislation may significantly […]
The University of Baltimore School of Law’s Intellectual Property Law Journal seeks articles for its Spring 2011 symposium issue. The symposium’s theme is: “The Incentive to Invent: Intellectual Property Protection and the U.S. Biotechnology and Pharmaceutical Industries.” The symposium seeks to explore issues and trends related to the role which intellectual property plays in the […]
For centuries now, farmers have been practicing agriculture by saving seeds from the harvest and using it for next year’s crop. Call it a form of insurance. Call it security. They may even exchange seeds with neighboring farms. This is their security blanket to keep poverty at bay as well as ensure crop genetic diversity. […]
The Intellectual Property Owners Association (IPO) an amicus curiae brief in the AMP v. USPTO and Myriad Genetics case, a lawsuit challenging patents covering diagnostic tests for mutations in genes. In the district court, the University of Utah and Myriad Genetics lost in a U.S. court ruling over patents for detecting inherited breast cancer related […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
